Avalo Therapeutics, Inc. SEC filings AVTX

Avalo Therapeutics, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to May 9, 2017. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (material agreement, agreement ended). The company's fiscal year ends on December 31.

Avalo Therapeutics, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 6, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 5, 2026 —
8-K Current report
Material agreement, Agreement ended
Nov 5, 2026 Nov 5, 2026
S-3ASR Automatic shelf registration Nov 5, 2026 —
424B5 Prospectus supplement Nov 5, 2026 —
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
SCHEDULE 13G Ownership over 5% (passive) Oct 29, 2026 —
4 Insider transaction Oct 2, 2026 Sep 30, 2026
4 Insider transaction Oct 2, 2026 Sep 30, 2026
4 Insider transaction Oct 2, 2026 Sep 30, 2026
4 Insider transaction Sep 18, 2026 Sep 16, 2026
4 Insider transaction Sep 11, 2026 Sep 10, 2026
4 Insider transaction Sep 1, 2026 Aug 28, 2026
4 Insider transaction Aug 19, 2026 Aug 17, 2026
4 Insider transaction Aug 19, 2026 Aug 17, 2026
144 Notice of proposed sale Aug 18, 2026 —
144 Notice of proposed sale Aug 17, 2026 —
144 Notice of proposed sale Aug 17, 2026 —
144 Notice of proposed sale Aug 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2026 —
4 Insider transaction Aug 12, 2026 Aug 11, 2026
4 Insider transaction Aug 12, 2026 Aug 10, 2026
144 Notice of proposed sale Aug 11, 2026 —
144 Notice of proposed sale Aug 10, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 7, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 7, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 6, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
4 Insider transaction Jul 29, 2026 Jul 27, 2026
EFFECT Filing Jul 28, 2026 —
424B3 Prospectus Jul 28, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jul 27, 2026 —
S-3 Shelf registration Jul 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 6, 2026 —
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jun 25, 2026 Jun 23, 2026
4 Insider transaction Jun 25, 2026 Jun 23, 2026
3 Initial insider ownership Jun 25, 2026 Jun 23, 2026
8-K Current report
Officer or director change
Jun 23, 2026 Jun 23, 2026
SCHEDULE 13G Ownership over 5% (passive) Jun 18, 2026 —
8-K Current report
Other events
Jun 16, 2026 Jun 16, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
8-K Current report
Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change
Jun 12, 2026 Jun 11, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 8, 2026 Jun 2, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jun 5, 2026 —
4 Insider transaction Jun 4, 2026 Jun 2, 2026
4 Insider transaction Jun 4, 2026 Jun 2, 2026
4 Insider transaction Jun 4, 2026 Jun 2, 2026
4 Insider transaction Jun 4, 2026 Jun 2, 2026
4 Insider transaction Jun 4, 2026 Jun 2, 2026
4 Insider transaction Jun 4, 2026 Jun 2, 2026
144 Notice of proposed sale Jun 2, 2026 —
4 Insider transaction Jun 1, 2026 May 28, 2026
SCHEDULE 13G Ownership over 5% (passive) May 29, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 26, 2026 —
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 19, 2026 May 15, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2026 —
10-Q Quarterly report May 13, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 13, 2026 May 13, 2026
SCHEDULE 13G Ownership over 5% (passive) May 12, 2026 —
4 Insider transaction May 11, 2026 May 7, 2026
144 Notice of proposed sale May 7, 2026 —
4 Insider transaction May 7, 2026 May 6, 2026
4 Insider transaction May 7, 2026 May 6, 2026
4 Insider transaction May 7, 2026 May 5, 2026
4 Insider transaction May 7, 2026 May 6, 2026
8-K Current report
Material agreement, Results of operations, Regulation FD disclosure
May 7, 2026 May 5, 2026
424B5 Prospectus supplement May 7, 2026 —
144 Notice of proposed sale May 6, 2026 —
144 Notice of proposed sale May 6, 2026 —
144 Notice of proposed sale May 6, 2026 —
144 Notice of proposed sale May 6, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 6, 2026 —
424B5 Prospectus supplement May 5, 2026 —
8-K Current report
Other events
May 5, 2026 May 5, 2026
4 Insider transaction May 1, 2026 Apr 29, 2026
144 Notice of proposed sale Apr 29, 2026 —
8-K Current report
Material agreement, Regulation FD disclosure
Apr 28, 2026 Apr 26, 2026
ARS Annual report to shareholders Apr 10, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 10, 2026 —
DEF 14A Proxy statement Apr 10, 2026 Apr 10, 2026
4 Insider transaction Apr 8, 2026 Apr 6, 2026
144 Notice of proposed sale Apr 6, 2026 —
4 Insider transaction Apr 3, 2026 Apr 1, 2026
4 Insider transaction Apr 3, 2026 Apr 1, 2026
144 Notice of proposed sale Apr 1, 2026 —
4 Insider transaction Apr 1, 2026 Mar 31, 2026
4 Insider transaction Apr 1, 2026 Mar 31, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 1, 2026 —
4 Insider transaction Mar 31, 2026 Mar 28, 2026
4 Insider transaction Mar 31, 2026 Mar 28, 2026
4 Insider transaction Mar 31, 2026 Mar 28, 2026
4 Insider transaction Mar 31, 2026 Mar 28, 2026
4 Insider transaction Mar 31, 2026 Mar 28, 2026
4 Insider transaction Mar 31, 2026 Mar 28, 2026
4 Insider transaction Mar 31, 2026 Mar 28, 2026
8-K Current report
Officer or director change
Mar 27, 2026 Mar 23, 2026
S-8 Employee stock plan registration Mar 23, 2026 —
10-K Annual report Mar 23, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 23, 2026 Mar 23, 2026
4 Insider transaction Mar 18, 2026 Mar 16, 2026
144 Notice of proposed sale Mar 16, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Mar 6, 2026 —
4 Insider transaction Mar 2, 2026 Feb 26, 2026
4 Insider transaction Mar 2, 2026 Feb 26, 2026
4 Insider transaction Mar 2, 2026 Feb 26, 2026
4 Insider transaction Mar 2, 2026 Feb 26, 2026
4 Insider transaction Mar 2, 2026 Feb 26, 2026
4 Insider transaction Mar 2, 2026 Feb 26, 2026
SCHEDULE 13G Ownership over 5% (passive) Feb 24, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 10, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 10, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 3, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 30, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 29, 2026 —
EFFECT Filing Jan 20, 2026 —
CORRESP Letter to the SEC Jan 15, 2026 —
UPLOAD Letter from the SEC Jan 14, 2026 —
8-K Current report
Results of operations, Other events
Jan 12, 2026 Jan 12, 2026
S-3 Shelf registration Jan 8, 2026 —
4 Insider transaction Jan 5, 2026 Dec 31, 2025
4 Insider transaction Jan 5, 2026 Dec 31, 2025
4 Insider transaction Dec 12, 2025 Dec 10, 2025
4 Insider transaction Dec 12, 2025 Dec 10, 2025
4 Insider transaction Dec 12, 2025 Dec 10, 2025
4 Insider transaction Dec 12, 2025 Dec 10, 2025
8-K Current report
Other events
Dec 2, 2025 Dec 2, 2025
4 Insider transaction Nov 17, 2025 Nov 14, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 13, 2025 —
S-8 Employee stock plan registration Nov 6, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
SCHEDULE 13G Ownership over 5% (passive) Oct 30, 2025 —
8-K Current report
Other events
Oct 29, 2025 Oct 29, 2025
8-K Current report
Other events
Oct 10, 2025 Oct 10, 2025
4 Insider transaction Oct 6, 2025 Oct 1, 2025
3 Initial insider ownership Oct 6, 2025 Oct 1, 2025
4 Insider transaction Oct 2, 2025 Oct 1, 2025
3 Initial insider ownership Oct 2, 2025 Oct 1, 2025
4 Insider transaction Oct 2, 2025 Sep 30, 2025
8-K Current report
Officer or director change, Other events
Oct 1, 2025 Sep 29, 2025
8-K Current report
Officer or director change
Sep 22, 2025 Sep 16, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 27, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
SCHEDULE 13G Ownership over 5% (passive) Aug 5, 2025 —
8-K Current report
Other events
Jun 20, 2025 Jun 20, 2025
4 Insider transaction Jun 18, 2025 Jun 17, 2025
4 Insider transaction Jun 18, 2025 Jun 17, 2025
4 Insider transaction Jun 18, 2025 Jun 17, 2025
4 Insider transaction Jun 18, 2025 Jun 17, 2025
4 Insider transaction Jun 18, 2025 Jun 17, 2025
4 Insider transaction Jun 18, 2025 Jun 17, 2025
4 Insider transaction Jun 18, 2025 Jun 17, 2025
4 Insider transaction Jun 18, 2025 Jun 17, 2025
3 Initial insider ownership Jun 18, 2025 Jun 17, 2025

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
AVTX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Wayne, PA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1534120
Former names
Cerecor Inc. (until Aug 18, 2021)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.